Makarand Jawadekar - Cardax Independent Director
| CDXI Stock | USD 0.0002 0.00 0.00% |
Director
Mr. Makarand Jawadekar, Ph.D., is Independent Director of the company. He is a pharmaceutical executive with over thirtyfive years of experience focused on research and development. From October 2017 to present, Dr. Jawadekar has served as Director and Chief Science Officer of Preveceutical Medical Inc., a Canadian pharmaceutical research and development company. Dr. Jawadekar also serves as a strategic advisor to pharmaceutical and biotechnology companies through his independent consultancy, Melinda Consulting, LLC, which he founded in 2010. From 1982 to 2010, Dr. Jawadekar held various technical, management, and business development positions at Pfizer, Inc., including Director, Portfolio Management Analytics, and Vice President, Asia Colleague Resource Group, for Pfizer Global RD since 2018.
| Age | 66 |
| Tenure | 6 years |
| Professional Marks | MBA |
| Phone | 808 457 1400 |
| Web | https://www.cardaxpharma.com |
Cardax Management Efficiency
The company has return on total asset (ROA) of (1.1256) % which means that it has lost $1.1256 on every $100 spent on assets. This is way below average. Cardax's management efficiency ratios could be used to measure how well Cardax manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Guylaine Saucier | SCOR PK | 68 | |
| Charles Gave | SCOR PK | 71 | |
| Daniel Valot | SCOR PK | 70 | |
| Kory Sorenson | SCOR PK | 49 | |
| Kevin Knoer | SCOR PK | 58 | |
| Andreas Brandstetter | SCOR PK | 45 | |
| Augustin Romanet | SCOR PK | 55 | |
| Vincent Foucart | SCOR PK | 39 | |
| Michele Aronvald | SCOR PK | 57 | |
| Thierry Derez | SCOR PK | 60 | |
| Wang Zhen | SCOR PK | 61 | |
| Guillaume Sarkozy | SCOR PK | 64 | |
| Augustin Beaune | SCOR PK | 57 | |
| Jane WickerMiurin | SCOR PK | 59 | |
| Vanessa Marquette | SCOR PK | 46 | |
| Thomas Saunier | SCOR PK | 51 | |
| Claude Tendil | SCOR PK | 72 | |
| Marguerite BerardAndrieu | SCOR PK | 40 | |
| JeanMarc Raby | SCOR PK | 59 | |
| Bruno Pfister | SCOR PK | 59 | |
| Peter Eckert | SCOR PK | 70 | |
Management Performance
| Return On Asset | -1.13 |
Cardax Inc Leadership Team
Elected by the shareholders, the Cardax's board of directors comprises two types of representatives: Cardax inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cardax. The board's role is to monitor Cardax's management team and ensure that shareholders' interests are well served. Cardax's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cardax's outside directors are responsible for providing unbiased perspectives on the board's policies.
| George Bickerstaff, Independent Director | ||
| Nicholas Mitsakos, Executive Chairman | ||
| Frank Herringer, Director | ||
| Terence Kelly, Independent Director | ||
| David Watumull, VP of Operations, Assistant Treasurer and Assistant Secretary | ||
| Michele Galen, Independent Director | ||
| Richard Morris, Secretary | ||
| Tamar Howson, Independent Director | ||
| Gilbert Shin, Vice President - Retail Sales and Marketing | ||
| Elona Kogan, Independent Director | ||
| Makarand Jawadekar, Independent Director | ||
| John Russell, CFO, Treasurer | ||
| Jon MD, Chief Officer |
Cardax Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Cardax a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -1.13 | |||
| Operating Margin | (5.85) % | |||
| Current Valuation | 5.34 M | |||
| Shares Outstanding | 802.52 K | |||
| Price To Earning | (22.00) X | |||
| Price To Sales | 0.0008 X | |||
| Revenue | 538.95 K | |||
| Gross Profit | 342.82 K | |||
| EBITDA | (2.64 M) | |||
| Net Income | (5.06 M) |
Pair Trading with Cardax
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cardax position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardax will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Cardax could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cardax when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cardax - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cardax Inc to buy it.
The correlation of Cardax is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cardax moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cardax Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cardax can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardax Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Complementary Tools for Cardax Pink Sheet analysis
When running Cardax's price analysis, check to measure Cardax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardax is operating at the current time. Most of Cardax's value examination focuses on studying past and present price action to predict the probability of Cardax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardax's price. Additionally, you may evaluate how the addition of Cardax to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |